Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth

Yong Zhao, Mei Juan Tu, Yi Feng Yu, Wei Peng Wang, Qiu Xia Chen, Jing Xin Qiu, Ai Xi Yu, Aiming Yu

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Fingerprint

Dive into the research topics of 'Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds